These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22750718)

  • 21. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
    Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3.
    Schwartz GG; Eads D; Rao A; Cramer SD; Willingham MC; Chen TC; Jamieson DP; Wang L; Burnstein KL; Holick MF; Koumenis C
    Carcinogenesis; 2004 Jun; 25(6):1015-26. PubMed ID: 14742320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue.
    Friedrich M; Diesing D; Cordes T; Fischer D; Becker S; Chen TC; Flanagan JN; Tangpricha V; Gherson I; Holick MF; Reichrath J
    Anticancer Res; 2006; 26(4A):2615-20. PubMed ID: 16886671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer.
    Murillo G; Matusiak D; Benya RV; Mehta RG
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):763-7. PubMed ID: 17257827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D: metabolism and biological actions.
    Henry HL; Norman AW
    Annu Rev Nutr; 1984; 4():493-520. PubMed ID: 6087861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous preadipocytes.
    Nimitphong H; Holick MF; Fried SK; Lee MJ
    PLoS One; 2012; 7(12):e52171. PubMed ID: 23272223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of vitamin D
    Sheng L; Anderson PH; Turner AG; Pishas KI; Dhatrak DJ; Gill PG; Morris HA; Callen DF
    J Steroid Biochem Mol Biol; 2016 Nov; 164():90-97. PubMed ID: 26485663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts.
    Avila E; Díaz L; Barrera D; Halhali A; Méndez I; González L; Zuegel U; Steinmeyer A; Larrea F
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):90-6. PubMed ID: 17079137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation.
    Vantieghem K; De Haes P; Bouillon R; Segaert S
    J Photochem Photobiol B; 2006 Oct; 85(1):72-8. PubMed ID: 16824767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.
    Kállay E; Bises G; Bajna E; Bieglmayer C; Gerdenitsch W; Steffan I; Kato S; Armbrecht HJ; Cross HS
    Carcinogenesis; 2005 Sep; 26(9):1581-9. PubMed ID: 15905206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells.
    Anderson PH; Atkins GJ; Findlay DM; Oloughlin PD; Welldon K; Vincent C; Morris HA
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):601-5. PubMed ID: 17254772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
    Segersten U; Björklund P; Hellman P; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the vitamin D system in cutaneous malignancies.
    Kamradt J; Rafi L; Mitschele T; Meineke V; Gärtner BC; Wolfgang T; Holick MF; Reichrath J
    Recent Results Cancer Res; 2003; 164():259-69. PubMed ID: 12899528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D status and breast cancer risk.
    Colston KW; Lowe LC; Mansi JL; Campbell MJ
    Anticancer Res; 2006; 26(4A):2573-80. PubMed ID: 16886666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.
    Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M
    Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue.
    McCarthy K; Laban C; Bustin SA; Ogunkolade W; Khalaf S; Carpenter R; Jenkins PJ
    Anticancer Res; 2009 Jan; 29(1):155-7. PubMed ID: 19331145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
    Miller GJ; Stapleton GE; Hedlund TE; Moffat KA
    Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxylases involved in vitamin D metabolism are differentially expressed in murine embryonic kidney: application of whole mount in situ hybridization.
    Yamagata M; Kimoto A; Michigami T; Nakayama M; Ozono K
    Endocrinology; 2001 Jul; 142(7):3223-30. PubMed ID: 11416045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.